Over the last 90 days, BioPharma Credit PLC has seen insider buying totaling £149.78. Director Harry Hyman made two purchases totaling £149.78. The net insider buying activity indicates a positive sentiment from management, with no reported sales during this period. The stock has seen a 3.4% increase in the last 90 days.